Root AW, Schneider J., and BuserelinCooperative Study Group. Effectiveness of the gonadotropin-releasing hormone agonist buserelin in the treatment of children with true and complete, central isosexual precocity. Adolesc Pediatr Gynecol. 1991;4:129-135.
2.
Ibañez L., Virdis R., Potau N., et al. Natural history of premature pubarche: an auxological study . J Clin Endocrinol Metab. 1992;74:254-257.
3.
Boepple PA, Crowley WFJr.Gonadotropin-releasing hormone analogues as therapeutic probes in human growth and development: evidence from children with central precocious puberty. Acta Paediatr Scand.1991 (suppl) ;372: 33-38.
4.
Oerter KE, Manasco P., Barnes KM, et al. Adult height in precocious puberty after long-term treatment with deslorelin. J Clin Endocrinol Metab. 1991;73: 1235-1240.
5.
Kauli R., Kornreich L., Laron Z.Pubertal development, growth and final height in girls with sexual precocity after therapy with the GnRH analogue D-TRP-6-LHRH. Horm Res . 1990;33:11-17.
6.
Oostdijk W., Hümmelink R., Odink Rjh, et al. Treatment of children with central precocious puberty by a slow-release gonadotropin-releasing hormone agonist. Eur J Pediatr.1990;149:308- 313.
7.
Kreiter M., Burstein S., Rosenfield RL, et al. Preserving adult height potential in girls with idiopathic true precocious puberty. J Pediatr.1990;117:364-370.
8.
Manasco PK, Pescovitz OH, Feuillan PP, et al. Resumption of puberty after long term luteinizing hormone-releasing hormone agonist treatment of central precocious puberty. J Clin Endocrine Metab.1988;67:368-372.
9.
Wheeler MD, Styne DMDrug treat ment of precocious puberty. Drugs1991;41:717-728.
10.
Pescovitz OH , Comite F., Hench K., et al The NIH experience with precocious puberty: diagnostic subgroups and re. sponse to short-term luteinizing hormone releasing hormone analogue therapy. J Pediatr.1986;108:47-54.
11.
Burton EM, Ball WS Jr, Crone K., et al. Hamartoma of the tuber cinereum: a comparison of MR and CT findings in four cases. AJWR.1989;10:497-501.
12.
Starceski PJ , Lee PA, Albright AL, et al. Hypothalamic hamartomas and sexual precocity: evaluation of treatment options. Am J Dis Child.1990;144:225-228.
13.
Grumbach MM , Kaplan SLRecent advances in the diagnosis and management of sexual precocity. Acta Paediatr Jpn.1988 ;30(suppl):155-175.
14.
Delemarre-Van De Waal HA, Wennink Jmb, Odink Rjh.Gonadotrophin and growth hormone secretion throughout puberty. Acta Paediatr Scand.1991 (suppl);372:26-31.
15.
Wheeler MD, Styne DMDiagnosis and management of precocious puberty. Pediatr Clin North Am. 1990;37:1255-1271.
16.
Marshall WA , Tanner JMVariations in pattern of pubertal changes in girls. Arch Dis Child.1969;44:291-303.
17.
Marshall WA , Tanner JMVariations in the pattern of pubertal changes in boys. Arch Dis Child.1970;45:13-23.
18.
Bidlingmaier F., Butenandt O., Knorr D.Plasma gonadotropins and estrogens in girls with idiopathic precocious puberty. Pediatr Res.1977;11:91-94.
19.
Brauner R., Malandry F., Fontoura M., et al. Idiopathic central precocious puberty in girls as a model of the effect of plasma estradiol level on growth, skeletal maturation and plasma insulin-like growth factor I. Horm Res. 1991 ;36:116-120.
20.
Greulich W., Pyle S.Radiologic Atlas of Hand and Wrist. Stanford, CA: Stanford University Press; 1959.
21.
Reiter EO, Kaplan SL, Conte FA, et al. Responsivity of pituitary gonadotropes to luteinizing hormone-releasing factor in idiopathic precocious puberty, precocious thelarche, and precocious adrenarche. Pediatr Res.1975;9:111-116.
22.
Oerter KE, Uriarte MM, Rose SR, et al. Gonadotropin secretory dynamics during puberty in normal girls and boys. J Clin Endocrinol Metab. 1990;71:1251-1258.
23.
Herman-Giddens ME, Sandler AD, Friedman NESexual precocity in girls: an association with sexual abuse?Am J Dis Child.1988;142:431-433.
24.
Parker KL, Baens-Bailon RG, Lee PADepot leuprolide acetate dosage for sexual precocity. J Clin Endocrinol Metab. 1991;73:50-52.
25.
Belchetz PE, Plant TM, Nakai Y., et al. Hypophysial responses to continuous and intermittent delivery of hypothalamic gonadotropin-releasing hormone. Science. 1978:202:631-633.
26.
Cook JS, Doty KL, Conn PM, et al. Assessment of depot leuprolide acetate dose-adequacy for central precocious puberty. J Clin Endocrinol Metab. 1992; 74:1206-1209.
27.
Swaenepoel C., Chaussain JL, Roger M.Long-term results of long-acting luteinizing-hormone-releasing hormone agonist in central precocious puberty. Horm Res. 1991;36:126-130.
28.
Oostdijk H. , Gevers EF, Drop Sls, et al. Growth and pubertal development during and after treatment with a slow-release gonadotropin-releasing hormone agonist in central precocious puberty. Horm Res. 1991 ;36:121-125.
29.
Laue L., Kenigsberg D., Pescovitz OH, et al. Treatment of familial male precocious puberty with spironolactone and testolactone. N Engl J Med.1989;320: 496-502.
30.
Feuillan PP , Foster CM, Pescovitz OH, et al. Treatment of precocious puberty in the McCune-Albright syndrome with the aromatase inhibitor testolactone. N Engl J Med.1986;315:1115-1119.
31.
Holland FJ, Fishman L., Bailey JD, et al. Ketoconazole in the management of precocious puberty not responsive to LHRH- analogue therapy. N Engl J Med.1985 ;312:1023-1028.
32.
Holland FJ, Kirsch SE, Selby R.Gonadotropin-independent precocious puberty ("testotoxicosis"): influence of maturational status on response to ketoconazole. J Clin Endrocrinol Metab. 1987;64:328-333.
33.
Kauli R., Pertzelan A., Prager-Lewin R., et al. Cyproterone acetate in treatment of precocious puberty. Arch Dis Child.1976;51:202-208.
